The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Why does obesity cause diabetes?
Open accessAbstract
The accumulation of an excessive amount of body fat can cause type 2 diabetes, and the risk of type 2 diabetes increases linearly with an increase in body mass index. Accordingly, the worldwide increase in the prevalence of obesity has led to a concomitant increase in the prevalence of type 2 diabetes. The cellular and physiological mechanisms responsible for the link between obesity and type 2 diabetes are complex and involve adiposity-induced alterations in β cell function, adipose tissue biology, and multi-organ insulin resistance, which are often ameliorated and can even be normalized with adequate weight loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It has also been shown to reduce both quality of life and life expectancy (2).”
From The Benefits of Exercise Training in Combination With Weight Loss Therapies (2025) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,061
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Cited by
Sorted by citations
Items 901–940 of 940
Sphingosine kinase 2 regulates adipocyte browning and whole-body metabolism
Brown, R. D. R., Weigel, C., Vijayan, Y., Tyc, K. M., Carter, C. R., Green, C. D., & Spiegel, S. (2026) · Science Advances · doi:10.1126/sciadv.aec7066
Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway
Wang, X., Zhang, N., Wang, M., Liu, J., Tong, L., Liang, X., Li, A., Gu, Y., Song, B., Xie, X., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47326-8
Cheng, Z. A., Wittmann, C., & Kishore, R. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01910-w
Lee, J., Hwang, S., Yi, H., & Kim, J. (2026) · Western Journal of Nursing Research · doi:10.1177/01939459261474260
Liu, D., Yu, Z., Dong, K., Lou, S., & Niu, J. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113513
Bulut, S., Kendir, G., Muhammed, M. T., Önem, E., Yılmaz, M. A., & Çakır, O. (2026) · ChemistrySelect · doi:10.1002/slct.74345
Xiang, D., Yuan, L., Liao, S., & Wang, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1887705
Almohammed, O. A., Alshaya, O. A., Alduhayshi, L. A., Alshaibani, S. T., Alhamed, M. S., Alzeer, M. A., Alabdullah, O. M., ibn Saqyan, M. F., Yami, M. S. A., Sheraim, N. B., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1847755
Molecular Distinctions, Diagnosis, and Mechanism-Based Therapies in Lipedema and Obesity
Güney, Y. E., Demiralay, S. Ç., & Keser, İ. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090892
Kadhim, N. J., Almashhadani, A. Q., Oriquat, G., Priya, G. P., Ray, S., Pal, A., Arora, V., Ibragimova, S., Mukhitdinov, O., Mahariq, I., et al. (2026) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2026.133104
Gao, M., Liu, M., Chu, A., Deng, S., Gao, J., Li, S., Jiang, D., Shen, Y., Wang, X., Lei, S., et al. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl53391
Sharma, S., Chaudhary, R., Hooda, T., Sharma, C., Dabral, S., Kumar, A., Bansal, S., & Gupta, S. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103833
How diet-related follow-up period affects risk of adverse health outcomes
Sabico, S., Al‐Daghri, N. M., & Grant, W. B. (2026) · Clinical Nutrition · doi:10.1016/j.clnu.2026.106784
Adipose tissue: an overlooked target of medical ionizing radiation and its metabolic consequences
Pereira, M. J., Silva, D., Marques, I. A., Santos, J., Matafome, P., & Abrantes, A. M. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1953578
Tahmasebi, Z., McEligot, A. J., Pang, K., Ho’opai, U., Kazner, C., Moran-Gomez, S., Avila, M., & Rodriguez, I. H. (2026) · The International Journal of Aging and Human Development · doi:10.1177/00914150261480665
Chen, V., Sima, S., Zhou, O., Yilamu, K., Kulkarni, V., Reddy, R., Rackham, M. D., Stevenson, A. L., Hsu, B., Singh, B., et al. (2026) · GeroScience · doi:10.1007/s11357-026-02513-3
Liu, W., He, F., Jiang, X., Liu, K., Zhang, Z., Liu, S., Zheng, J., & Liu, H. (2026) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2026.140909
Zhu, J., Tang, X., Zhu, C., Zhang, Y., Rao, Z., Zhu, Q., & Zheng, L. (2026) · Journal of International Medical Research · doi:10.1177/03000605261487246
Mackey, S., Egan, C., & Elkind-Hirsch, K. E. (2026) · Therapeutic Advances in Reproductive Health · doi:10.1177/26334941261481473
Mathur, A. S., Nandi, D., Banerjee, A., & Mehta, V. (2026) · Nutrition and Health · doi:10.1177/02601060261487857
Forero, J. A. S., Rendo, A. G., Menchén-Trujillo, B., de Paz, F. M., & Martín‐Fernández, J. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08926-5
Tereshchenko, A., Gálvez, B. G., & Tello, J. A. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261474093
Silva, G. A. V., Tuplin, E. W. N., Kumar, V. M., Chow, M. R., Lowry, D. E., Patterson, R. A., Cho, N. A., Biddle, M. S., Sales, K. M., & Reimer, R. A. (2026) · Nutrition · doi:10.1016/j.nut.2026.113438
Eighty Years After Vague: Advances in Understanding Ectopic Fat and Metabolic Dysfunction
Conte, C., Sumithran, P., le Roux, C. W., Miras, A. D., & Gaal, L. V. (2026) · Obesity Reviews · doi:10.1111/obr.70229
Chronic ileitis ameliorates hyperglycemia via a 3-HB/NKX6.1 axis in mice
Fang, Y., Zheng, C., Jiang, P., Luo, J., Xiang, Y., Yang, J., Li, Y., Jiang, R., & Xu, G. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112920
Hussein, N., Musa, D. H., Abozait, H. J., Abdulraheem, H. F., Mahfodh, D. S., Mohammed, W. M., Majed, H. S., & Naqid, I. A. (2026) · Journal of Obesity · doi:10.1155/jobe/5599283
Glucose tolerance declines with age in a long-lived rodent species ( Octodon degus )
Garcia, T., Low, J., Sato, Y., Choi, A., Craig, A., Cicco, A. D., & Bauer, C. M. (2026) · Royal Society Open Science · doi:10.1098/rsos.252325
Mróz, M., Litewski, S., Parchem, K., & Kusznierewicz, B. (2026) · Food Chemistry · doi:10.1016/j.foodchem.2026.151383
Wang, Y., Liu, Z., Wang, S., Lv, C., El-Seedi, H. R., Khalifa, S. A. M., & Wang, H. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70351
Qiao, W., Ku, C., Kumar, G. V. N., Brown, J. D., Wu, M., Li, C., Xie, J., Meng, H., Sun, L., Zhou, T., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70655
Bose, P., & Singh, B. P. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107531
Longmore, D. K., MacKechnie, G. P. D., Huntington, P. A., Chen, Z. H., de Groot, J., Mikkonen, S. J., Mykkänen, J., Pätsi, S., Puusepp, T., Fischer, K., et al. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104231
Lee, C., Yu, K., Liu, X., Huang, J.-Q., & Yao, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10928875/v1
More than just adipose: the impact of GLP1RA on lean tissue
Julien, M., Jeromson, S., & Wright, D. C. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.90062.2026
Liu, Y., Wang, J., Yu, Y., Chen, X., Chen, X., Chen, Y., Chen, G., & Liu, S. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02801-6
Obesity as a Comorbid Condition and a Risk Factor for a Suboptimal Response to Anti-VEGF therapy
Likhvantseva, V. G., Likhvantseva, V. G., Kapkova, S. G., Plieva, H. M., Tretyak, E. B., & Рычкова, С. И. (2026) · Ophthalmology in Russia · doi:10.18008/1816-5095-2026-3-639-651
Pekacar, S., Özüpek, B., Bulut, S., Yılmaz, M. A., Çakır, O., Tarhan, A., Tuğay, O., & Orhan, D. D. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71852
Nwaneri, S. C., & Odukoya, O. O. (2026) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-3-032-18927-1_17
Jian, L., Luo, C., Liu, L., Yang, X., & Luo, J. (2026) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203261493343
Boutari, C., & Mantzoros, C. S. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156812
Metadata
- Authors
- Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- Istituto di Fisiologia Clinica (IT)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Klein, Samuel
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 34
- Issue
- 1
- Pages
- 11-20
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC8740746
- OpenAlex
- W4206513048
- Cited by
- 939
- References
- 112
- Citations by year
- 2026: 196 · 2025: 329 · 2024: 249 · 2023: 112 · 2022: 51
- FWCI
- 29.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 368 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Sigrid Juséliuksen Säätiö
- Inventiva Pharma
- National Institutes of Health (R01-DK099110, DK20579, RC2-DK118620, UL1TR002345, DK56341, R01-DK55758)
- Academy of Finland
- Eli Lilly and Company
- Gilead Sciences
- Janssen Pharmaceuticals
- Merck
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, type 2 diabetes, body mass index, beta-cell dysfunction, adipose tissue, insulin resistance, weight loss, diabetes pathogenesis
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Obesity, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
